"Der Blick von der Klinik Wald schweift vom Obersee über die Linthebene bis zum Voralpenkamm. Der individuelle Weg zurück zur grösstmöglichen Selbstständigkeit und optimalen Lebensqualität beginnt für die Patientinnen und Patienten – viele mit schweren, komplexen Krankengeschichten – jeden Morgen mit dieser Aussicht. Die Standortqualität geht einher mit der Qualität der spezifischen Rehabilitationsleistungen in Wald – ambulant und stationär. Die Zürcher RehaZentren | Klinik Wald mit 150 Betten deckt fünf grosse Fachbereiche der Rehabilitation ab: die muskuloskelettale, neurologische, pulmonale, kardiovaskuläre und die internistische-onkologische Rehabilitation."

During the past decade, Zürcher RehaZentrum Wald conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 3 clinical trials were completed, i.e. on average, 37.5% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Zürcher RehaZentrum Wald" #1 sponsor was "Idorsia Pharmaceuticals Ltd." with 2 trials, followed by "University of Zurich" with 2 trials sponsored, "Boehringer Ingelheim" with 1 trials sponsored, "Kaia Health Software" with 1 trials sponsored and "University Hospital, Basel, Switzerland" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Zürcher RehaZentrum Wald" #1 collaborator was "Swiss Federal Institute of Technology in Zurich (ETH Zurich)" with 1 trials as a collaborator, "Swiss National Science Foundation" with 1 trials as a collaborator and "Tyromotion AG" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Zürcher RehaZentrum Wald" are "Insomnia Disorder" (2 trials), "Pulmonary Disease, Chronic Obstructive" (2 trials), "Acute Stroke" (1 trials), "Chronic Disease" (1 trials) and "Lung Diseases, Obstructive" (1 trials). Many other conditions were trialed in "Zürcher RehaZentrum Wald" in a lesser frequency.

Most popular intervention types in "Zürcher RehaZentrum Wald" are "Drug" (4 trials), "Other" (3 trials), "Device" (2 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Daridorexant 25 mg" (2 trials), "Daridorexant 50 mg" (2 trials), "Placebo" (2 trials), "Daridorexant 10 mg" (1 trials) and "Exercise" (1 trials). Other intervention names were less common.

The vast majority of trials in "Zürcher RehaZentrum Wald" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Zürcher RehaZentrum Wald". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Zürcher RehaZentrum Wald, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Zürcher RehaZentrum Wald, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".